Nothing here is medical advice, a therapeutic claim, or a dosing recommendation for human use
UK GLP-1 Drugs Market Trends As the use of GLP-1 drugs is increasing, the industries in the UK are developing various such candidates
You know, As we mentioned, the polling shows these medications are becoming
375 (4):311-322 doi:10.1056/NEJMoa1603827 39
4 Between GLP-1s ability to boost insulin and control glucagon for healthy blood sugar levels and to help slow digestion and help you feel full faster, the buzz around this hormone makes a lot of sense
Analysts now predict that the GLP-1 market could reach $71 billion by 2032, driven by increasing demand for these medications in the treatment of obesity, type 2 diabetes, and cardiovascular conditions